Ki-67 immunostaining and other prognostic factors including tobacco smoking in patients with resected nonsmall cell lung carcinoma

Cancer

Volumn 89, Issue 7, 2000, Pages 1457-1465

  Shiba, Mitsutoshi ^a   Kohno, Hiromasa ^a   Kakizawa, Kimitaka ^a   Iizasa, Toshihiko ^a   Otsuji, Mizuto ^a   Saitoh, Yukio ^a   Hiroshima, Kenzo ^a   Ohwada, Hidemi ^a   Fujisawa, Takehiko ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ki 67 antigen; Multivariate analysis; Nonsmall cell lung carcinoma (NSCLC); Prognosis; Surgery; Tobacco smoking

Indexed keywords

KI 67 ANTIGEN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CIGARETTE SMOKING; FEMALE; HUMAN; IMMUNOCHEMISTRY; LABELING INDEX; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMAN; KI-67 ANTIGEN; LUNG NEOPLASMS; MALE; MIDDLE AGE; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SMOKING; SURVIVAL ANALYSIS;

EID: 0034307043     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20001001)89:7<1457::AID-CNCR7>3.0.CO;2-L     Document Type: Article

References (35)

1. Lung cancer: Epidemiology and risk factors
2. Cancer statistics, 1997
3. Revisions in the international system for staging lung cancer
4. Implications of staging in lung cancer
5. Prognostic markers in resectable non-small cell lung cancer
6. Cell proliferation kinetics in human solid tumors: Relation to probability of metastatic dissemination and long term survival
7. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67
8. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections
9. Ki-67 immunostaining and survival in operable lung cancer
10. Prognostic significance of the proliferation index in surgically resected non-small-cell lung cancer
11. Prognostic significance of Ki67 labeling in resected non small cell lung cancer
12. A prognostic model of recurrence and death in stage I NSCLC utilizing presentation, histopathology, and oncoprotein expression
13. Smoking before surgery predicts poor long-term survival in stage I nonsmall cell lung carcinoma
14. Clonal genetic alterations in the lungs of current and former smokers
15. p53 Mutation in non-small cell lung cancer in Japan: Association between mutation and smoking
16. Abnormal p53 expression in human lung cancer is associated with histologic subtypes and patient smoking history
17. K-ras oncogene activation in lung adenocarcinomas from former smokers
18. Nonparametric estimation from incomplete observation
19. Chi-square tests with one degree of freedom: Extensions of the Mantel-Haenszel procedure
20. Regression models and life tables
21. Ploidy as a prognostic determinant in surgically treated lung cancer
22. K-ras oncogene activation as a prognostic marker in adenocarcinoma of lung
23. Prognostic significance of p53 mutation and 3p deletion in primary resected NSCLC
24. p185 Neu expression in human lung adenocarcinomas predicts shortened survival
25. bcl-2 Protein in NSCLC
26. A cell kinetic study of pulmonary adenocarcinoma by an immunoperoxidase procedure after bromodeoxyuridine labeling
27. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibody in fixed, embedded tissues. Comparison with flow cytometric analysis
28. Cell cycle analysis detecting endogenous nuclear antigens: Comparison with BrdU-in vivo labeling and an application to lung tumors
29. Proliferating cell nuclear antigen (PCNA) expression in formalin fixed tissue of non-small cell lung carcinoma
30. Value of Ki-67 immunostaining in preoperative biopsies of carcinomas of the lung
31. Preoperative smoking habits and postoperative pulmonary complications
32. Smoking abstinence and small cell lung cancer survival
33. Prognostic factors for surgically treated lung adenocarcinoma patients, with special reference to smoking habit
34. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction
35. p53 Gene mutation are associated with decreased sensitivity of human lymphoma cells to DNA damaging cells